Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non‐small cell lung cancer

Association of anaplastic lymphoma kinase variants and alterations with ensartinib response duration in non‐small cell lung cancer

Abstract Background Here, we aimed to assess the association of ALK variants and alterations with ensartinib response duration in NSCLC, and explore the potential value of computed tomography (CT) radiomic features in predicting progression‐free survival (PFS). Methods We enrolled 88 patients with i...

Full description

Bibliographic Details
Main Authors: Donghui Hou, Xiaomin Zheng, Wei Song, Xiaoqing Liu, Sicong Wang, Lina Zhou, Xiuli Tao, Lv Lv, Qi Sun, Yujing Jin, Zewei Zhang, Lieming Ding, Ning Wu, Shijun Zhao
Format: Article
Language:English
Published: Wiley 2021-09-01
Series:Thoracic Cancer
Subjects:
ALK fusion
ensartinib
gene mutation
progression‐free survival
radiomics
Online Access:https://doi.org/10.1111/1759-7714.14083

Internet

https://doi.org/10.1111/1759-7714.14083

Similar Items